Apelin decreased right ventricular injury and improved cardiac function in monocrotaline-induced pulmonary hypertension rats, establishing apelin as a cardioprotective peptide for pulmonary hypertension.
Key findingApelin decreased right ventricular injury and improved cardiac function in monocrotaline-induced pulmonary hypertension rats, establishing apelin as a
What the researchers found
Apelin decreased right ventricular injury and improved cardiac function in monocrotaline-induced pulmonary hypertension rats, establishing apelin as a cardioprotective peptide for pulmonary hypertension.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
American journal of physiology. Heart and circulatory physiology, 296(6), H2007-14
Citation
Falcão-Pires, Inês; Gonçalves, Nádia; Henriques-Coelho, Tiago; Moreira-Gonçalves, Daniel; Roncon-Albuquerque, Roberto; Leite-Moreira, Adelino F. (2009). Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.. American journal of physiology. Heart and circulatory physiology, 296(6), H2007-14. https://doi.org/10.1152/ajpheart.00089.2009